Immunotherapy is a type of cancer treatment that helps fight cancer. It is used to manage the disease by suppressing, enhancing, or inducing an immune response. Some immunotherapies, known as activation immunotherapies, are designed to enhance or elicit an immune response. While, some immunotherapies, known as suppression immunotherapies, are reduce or suppress the immune response. Moreover, cell-based immunotherapies are also used to treat some types of cancer. Immune effector cells, such as lymphocytes, dendritic cells, macrophages, natural killer cells (NK Cell), cytotoxic T lymphocytes (CTL), etc. help fight against cancer by aiming at abnormal antigens articulated on the facade of the tumor cells.
Get Free Sample PDF Copy (Including Full TOC, List of Tables & Figures, Chart) @
High prevalence of cancer and autoimmune diseases and high demand for immunotherapy drugs is expected to augment the growth of the global immunotherapy drugs market over the forecast period. For instance, according to the World Health Organization (WHO), in 2018, cancer caused around 9.6 million deaths around the world. Of which, around 70% of cancer deaths occur in low and middle-income countries.
Moreover, growing need for mAbs is expected to boost growth of the global immunotherapy drugs market. mAbs have a high affinity for specific disease cells as well as areas that require treatment. These mAbs can also be used in radio immunotherapy and antibody-directed enzyme prodrug therapy. Increasing use of these antibodies in drug development is also expected to propel growth of the global immunotherapy drugs market.
Furthermore, materialization of biosimilars is expected to drive growth of the immunotherapy drugs market during the forecast period. Unlike generic drugs, which contain the same active pharmaceutical ingredients as the original drugs, biosimilars are almost identical to those of their manufacturer’s biological compounds. The sale of biosimilars among both the hospitals and patients is also expected to increase over the forecast period. This in turn is also expected to drive growth of the market.
High cost of immunotherapy drugs is expected to hamper growth of the immunotherapy drugs market during the forecast period.
Ask for PDF Brochure @
Among regions, North America and Asia Pacific are expected to witness robust growth in the global immunotherapy drugs market due to high prevalence of cancer and increasing demand for immunotherapy drugs in these regions. For instance, as per the National Cancer Institute, in 2016, an estimated 1,685,210 new cases of cancer will be diagnosed in the United States and 595,690 will die from the disease. Immunotherapy drugs are used as a first line of treatment in the management of cancer.
In Asia Pacific, growth of the market is attributed to low cost of manufacturing of these drugs and favorable reimbursement scenario in major countries such as Belgium, France, Spain, Italy, Japan, Australia, China, and the U.K. For instance, in June 2018, Merck & Co. Inc. and the National Health Service (NHS) England teamed up to reimburse the cost of these drugs, as the National Institute for Health and Care Excellence (NICE) recommends National Health Service to provide reimbursements for these drugs and make them affordable for people.
Major players active in the global immunotherapy drugs market Johnson & Johnson, Amgen, Inc., AstraZeneca, Bristol-Myers Squibb, Merck & Co., Inc. AbbVie, F. Hoffmann-La Roche AG, GlaxoSmithKline, Johnson & Johnson, and Novartis International AG, among others.
In April 2018, Illumina Inc. and Bristol-Myers Squibb Company (BMS) teamed up to develop and commercialize in-vitro diagnostic assays in support of BMS oncology portfolio.
In April 2018, Allogene Therapeutics and Pfizer Inc. signed an asset contribution agreement for Pfizer’s portfolio of assets related to allogeneic chimeric antigen receptor T cell (CAR T) therapy, an investigational immune cell therapy approach to treat cancer.
Reasons to Buy this Immunotherapy Drugs Market Report
➡ Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging Immunotherapy Drugs market
➡Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging Immunotherapy Drugs market
➡Leading company profiles reveal details of key Immunotherapy Drugs market players emerging five operations and financial performance
➡Add weight to presentations and pitches by understanding the future growth prospects of the emerging Immunotherapy Drugs market with five year historical forecasts
➡Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region .
𝐁𝐮𝐲 𝐓𝐡𝐢𝐬 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐟𝐟 @
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Immunotherapy Drugs Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Immunotherapy Drugs Industry Impact
Chapter 2 Global Immunotherapy Drugs Competition by Types, Applications, and Top Regions and Countries
2.1 Global Immunotherapy Drugs (Volume and Value) by Type
2.3 Global Immunotherapy Drugs (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Immunotherapy Drugs Sales, Consumption, Export, Import by Regions
Chapter 5 North America Immunotherapy Drugs Market Analysis
Chapter 6 East Asia Immunotherapy Drugs Market Analysis
Chapter 7 Europe Immunotherapy Drugs Market Analysis
Chapter 8 South Asia Immunotherapy Drugs Market Analysis
Chapter 9 Southeast Asia Immunotherapy Drugs Market Analysis
Chapter 10 Middle East Immunotherapy Drugs Market Analysis
Chapter 11 Africa Immunotherapy Drugs Market Analysis
Chapter 12 Oceania Immunotherapy Drugs Market Analysis
Chapter 13 South America Immunotherapy Drugs Market Analysis
Chapter 14 Company Profiles and Key Figures in Immunotherapy Drugs Business
Chapter 15 Global Immunotherapy Drugs Market Forecast (2021-2028)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027